Inmedic Group ApS: Financial statements 2021
CVR: 40711171
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Inmedic Group ApS (CVR 40711171) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -156,219 and a net result of DKK -166,144. Equity in the 2021 report amounted to DKK 328,386. The solvency ratio was 99.1%.
- Gross Profit
- DKK -156,219
- Profit/Loss
- DKK -166,144
- Equity
- DKK 328,386
- Total Assets
- DKK 331,386
- Employees
- 0
Official annual report
Find more companies like Inmedic Group ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Inmedic Group ApS has published its interim report for the period August 14, 2019 – December 31, 2020.
About Inmedic Group ApS
Inmedic Group ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Nordic Cannabis Research ApS. The management consists of Henrik Lund Uth. The company is owned by DAM-ANDERSEN ApS, HEMAR ApS and Schejbel Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 102,384 and a net result of DKK 563,568 compared with DKK 441,754 the year before. Equity in the 2025 report amounted to DKK 2,131,008.